- CA$14.27m
- CA$2.54m
- CA$6.21m
- 48
- 53
- 41
- 45
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.57 | 4.11 | 3.53 | 4.33 | 6.21 |
Cost of Revenue | |||||
Gross Profit | 2.95 | 2.17 | 1.84 | 2.39 | 3.08 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.1 | 5.36 | 4.38 | 4.56 | 6.38 |
Operating Profit | -0.525 | -1.25 | -0.85 | -0.23 | -0.168 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.161 | -0.578 | -0.212 | 1.13 | 0.083 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.11 | -0.578 | -0.227 | 1.13 | 0.083 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.11 | -0.578 | -0.227 | 1.13 | 0.083 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.11 | -0.578 | -0.227 | 1.13 | 0.083 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.004 | -0.02 | -0.008 | 0.04 | 0.003 |